13 results match your criteria: "St Radboud University Medical Center[Affiliation]"

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial.

Eur Heart J

November 2020

Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Article Synopsis
  • The COMPARE trial found that 3-year losartan treatment had a small beneficial effect on aortic root dilatation in adults with Marfan syndrome, but no significant impact on overall clinical outcomes was observed due to short follow-up.
  • The current study aimed to assess long-term clinical outcomes after losartan treatment, following a median follow-up of 8 years, with 75 patients continuing on losartan and 78 in the control group.
  • Results indicated a reduction in clinical events for those who continued losartan, particularly noting differences in aortic root replacement, while other serious events mostly occurred in patients with pre-existing aortic interventions.*
View Article and Find Full Text PDF

Administration of azole antifungals to tacrolimus-treated solid organ recipients results in a major drug-drug interaction characterized by increased exposure to tacrolimus. The magnitude of this interaction is highly variable but cannot currently be predicted. We performed a retrospective analysis of 126 solid organ recipients (95 lung, 31 kidney) co-treated with tacrolimus and voriconazole (n = 100) or posaconazole (n = 26).

View Article and Find Full Text PDF

Introduction: Hypertension in kidney transplant recipients (KTRs) is a risk factor for cardiovascular mortality and graft loss. Data on the prevalence of hypertension and uncontrolled hypertension (uHT) in paediatric and young adult KTRs are scarce. Also, it is unknown whether 'transition' (the transfer from paediatric to adult care) influences control of hypertension.

View Article and Find Full Text PDF

Cerebral Critical Closing Pressure During Infusion Tests.

Acta Neurochir Suppl

July 2017

Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

We studied possible correlations between cerebral hemodynamic indices based on critical closing pressure (CrCP) and cerebrospinal fluid (CSF) compensatory dynamics, as assessed during lumbar infusion tests. Our data consisted of 34 patients with normal-pressure hydrocephalus who undertook an infusion test, in conjunction with simultaneous transcranial Doppler ultrasonography (TCD) monitoring of blood flow velocity (FV). CrCP was calculated from the monitored signals of ICP, arterial blood pressure (ABP), and FV, whereas vascular wall tension (WT) was estimated as CrCP - ICP.

View Article and Find Full Text PDF

Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by flow cytometry (FCM) since the publication of the World Health Organization 2008 classification of myeloid neoplasms. An international working party initiated within the European LeukemiaNet and extended to include members from Australia, Canada, Japan, Taiwan and the United States has, through several workshops, developed and subsequently published consensus recommendations. The latter deal with preanalytical precautions, and propose small and large panels, which allow evaluating immunophenotypic anomalies and calculating myelodysplasia scores.

View Article and Find Full Text PDF

A case of esophageal duplication cyst with a 13-year follow-up period.

Endoscopy

September 2005

Dept. of Medicine, Division of Gastroenterology and Hepatology, St. Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

Benign esophageal cysts are very rare embryonic malformations. In adults, esophageal cysts are mostly asymptomatic. Complications can occur due to mass effects.

View Article and Find Full Text PDF

For safety reasons, two leads for left ventricular pacing were implanted in the coronary sinus of a pacemaker dependent patient with an artificial tricuspid valve prosthesis.

View Article and Find Full Text PDF

Pheochromocytomas are dangerous tumors that, although a rare cause of hypertension, require consideration among large numbers of patients. The resulting low prevalence of the tumor among tested populations and the inadequacies of commonly used biochemical tests make excluding or confirming the tumor an often difficult and time-consuming task. Recognition that catecholamines are metabolized to free metanephrines within pheochromocytoma tumor cells, and that this process is independent of catecholamine release, provides a rationale for use of these metabolites in the biochemical diagnosis of pheochromocytoma.

View Article and Find Full Text PDF

Biochemical diagnosis of pheochromocytoma: which test is best?

JAMA

March 2002

Department of Internal Medicine, St Radboud University Medical Center, Geert Grooteplein Zuid 8, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.

Context: Diagnosis of pheochromocytoma depends on biochemical evidence of catecholamine production by the tumor. However, the best test to establish the diagnosis has not been determined.

Objective: To determine the biochemical test or combination of tests that provides the best method for diagnosis of pheochromocytoma.

View Article and Find Full Text PDF